human
immunotherapi
checkpoint
blockad
achiev
signific
breakthrough
recent
year
studi
checkpoint
blockad
vaccin
canin
melanoma
test
safeti
immunogen
five
healthi
adult
dog
receiv
mixtur
three
replicationdefect
chimpanzeederiv
adenovir
vector
one
express
mous
fibroblastassoci
protein
mfap
other
express
canin
melanomaassoci
antigen
fuse
herp
glycoprotein
checkpoint
inhibitor
herp
viru
entri
mediat
hvem
pathway
vaccin
mixtur
shown
well
toler
increas
frequenc
activ
cell
secret
interferon
ifn
tumor
necrosi
factor
tnf
interleukin
il
alon
combin
four
five
five
dog
respect
avoid
excess
bleed
respons
analyz
dog
respond
increas
frequenc
mfapspecif
activ
cell
result
safetyimmunogen
trial
invit
test
checkpoint
blockad
vaccin
combin
dog
melanoma
incid
cancer
high
dog
male
femal
case
per
dogyear
respect
malign
melanoma
one
common
canin
cancer
estim
annual
case
oral
melanoma
per
dog
incid
increas
age
certain
breed
cocker
spaniel
golden
retriev
labrador
retriev
higher
risk
other
dachshund
beagl
treatment
option
includ
radic
surgeri
immunotherapi
radiat
therapi
chemotherapi
hyperthermia
two
latter
treatment
option
gener
ineffect
prognosi
vari
accord
tumor
stage
treatment
even
radic
surgeri
dog
stage
ii
iii
melanoma
die
averag
within
less
year
human
immunotherapi
use
checkpoint
blockad
transfer
vitro
expand
tumorinfiltr
lymphocyt
til
cell
chimer
antigen
receptor
car
cancer
vaccin
achiev
signific
breakthrough
recent
year
overal
efficaci
cancer
vaccin
costeffect
option
cancer
immunotherapi
warrant
improv
major
barrier
exhaust
tumor
antigen
ta
specif
til
within
tumor
microenviron
tme
recruit
immunoinhibitori
cell
metabol
hostil
milieu
tcell
exhaust
character
increas
express
immunoinhibitori
molecul
btla
other
lead
loss
function
eventu
cell
death
immunosuppress
part
revers
antibodi
block
interact
immunoinhibitor
cell
ligand
human
checkpoint
blockad
therapi
mainli
focus
treatment
block
antibodi
ligand
result
tumor
regress
certain
cancer
patient
use
differ
twoprong
approach
enhanc
vaccineinduc
taspecif
tcell
respons
reduc
cell
exhaust
within
tme
fusion
ta
herp
simplex
viru
glycoprotein
g
block
bind
immunoinhibitori
band
tcell
lymphocyt
attenu
btla
herp
viru
entri
mediat
hvem
enhanc
tcell
stimul
immunoinihbitori
milieu
tme
reduc
deplet
cell
tumor
stroma
fibroblast
vaccin
target
cancerassoci
fibroblast
caf
fibroblastassoci
protein
fap
elicit
vaccineinduc
anticaf
tcell
respons
turn
reduc
tcell
exhaust
delay
tumor
progress
previous
test
melanoma
vaccin
base
chimpanzeeorigin
replicationdefect
adenoviru
vector
serotyp
express
epitop
differ
maa
administ
togeth
second
vector
express
fap
demonstr
signific
protect
transplant
melanoma
cell
transgen
melanomapron
tyr
creer
braf
ca
pten
loxlox
mice
develop
combin
maafap
vaccin
treatment
dog
melanoma
conduct
safeti
immunogen
studi
healthi
beagl
use
vector
express
canin
c
tyrosinaserel
protein
within
gd
tyrosinaserel
protein
within
gd
mfap
vaccin
mixtur
well
toler
induc
tcell
respons
mfap
avoid
take
excess
blood
volum
dog
immun
respons
analyz
vector
describ
previous
sequenc
synthes
integr
dna
technolog
clone
age
bp
bamhi
bp
site
gd
gene
carri
pshuttl
vector
express
cassett
excis
rare
cutter
iceu
pisc
clone
molecular
clone
cut
enzym
recombin
molecular
clone
identifi
transform
bacteria
diagnost
restrict
enzym
digest
construct
molecular
clone
correct
insert
digest
paci
uniqu
site
restrict
enzym
locat
directli
adjac
itr
viral
genom
molecular
clone
dna
transfect
semiconflu
monolay
hek
cell
american
tissu
cultur
collect
atcc
viral
rescu
viral
plaqu
becam
visibl
cell
harvest
viru
releas
freezethaw
viru
expand
sever
passag
hek
cell
largescal
stock
flask
produc
viru
purifi
buoyant
densiti
ultracentrifug
cscl
gradient
follow
desalt
biogel
column
viru
particl
vp
content
determin
spectrophotometri
nm
latter
determin
puriti
prepar
titer
vp
determin
use
formula
od
dilut
content
infecti
unit
iu
determin
nest
revers
transcript
pcr
hexonspecif
primer
cell
infect
serial
dilut
vector
genet
integr
ident
vaccin
assess
upon
isol
viral
dna
recombin
dna
digest
set
restrict
enzym
parallel
molecular
clone
analyz
gel
electrophoresi
vaccin
genom
show
expect
band
pattern
assay
use
analyz
dna
serial
passag
viral
vector
hek
cell
vector
genom
dna
restrict
enzym
band
pattern
conserv
indic
vaccin
genet
stabl
batch
test
endotoxin
limulu
amebocyt
lysat
lal
gelclot
method
use
commerci
kit
vaccin
contain
detect
endotoxin
vector
test
steril
cultur
lb
medium
h
bacteri
fungal
growth
observ
dog
hous
individu
ft
ft
elev
pen
construct
expand
galvan
metal
floor
cage
equip
solid
polypropylen
rest
panel
individu
food
water
contain
pen
locat
climatecontrol
room
equip
environment
control
system
dog
maintain
condit
rang
rel
humid
cours
trial
artifici
light
provid
cover
overhead
fluoresc
fixtur
set
timer
provid
cycl
altern
period
h
h
light
pen
clean
daili
sanit
least
weekli
water
pail
empti
rins
daili
clean
necessari
dog
confin
individu
remov
pen
individu
group
enrich
prior
day
thereaft
dog
remov
hous
daili
clean
measur
rectal
temperatur
bodi
weightsphys
exam
treatment
blood
collect
dog
offer
dri
commerci
dog
food
lab
diet
canin
cup
per
day
divid
similar
pm
portion
confin
fresh
potabl
water
suppli
local
commerci
util
water
avail
ad
libitum
stainless
steel
pail
replenish
least
twice
daili
prior
initi
studi
protocol
review
approv
east
tennesse
clinic
research
etcr
rockwood
tn
institut
anim
care
use
committe
dog
acclimat
week
dog
immun
intramuscularli
three
vaccin
given
differ
site
paralumbar
prescapular
ml
steril
salin
contain
vp
vp
vp
health
statu
dog
assess
prior
vaccin
differ
time
point
vaccin
dog
bled
vaccin
h
vaccin
blood
chemistri
includ
test
glucos
total
bilirubin
total
protein
urea
nitrogen
phosphoru
sodium
chlorid
magnesium
alanin
aminotransferas
alt
addit
sampl
underw
routin
complet
blood
count
cbc
hematolog
studi
show
abnorm
data
shown
dog
bled
day
vaccin
blood
immedi
transfer
edtacontain
tube
ship
wistar
institut
test
tcell
respons
pbmc
isol
ficol
paqu
plu
ge
healthcar
gradient
centrifug
min
room
temperatur
rpm
red
blood
cell
lyse
rbc
lysi
buffer
ebiosci
cell
wash
count
cryopreserv
fetal
bovin
serum
dmso
test
antibodi
shown
tabl
either
direct
canin
sequenc
manufactur
confirm
crossreact
canin
protein
confirm
appropri
reactiv
antibodi
surfac
marker
initi
test
pbmc
normal
dog
part
studi
data
shown
suppl
tabl
posit
cell
within
live
lymphoid
cell
gate
marker
show
cell
doubleposit
show
cell
tripleposit
intracellular
stain
initi
test
preble
two
enrol
younger
dog
upon
polyclon
activ
percent
cytokin
posit
cell
within
gate
shown
suppl
tabl
frequenc
cell
mfap
assess
intracellular
cytokin
stain
ic
stimul
mfap
peptid
pool
frozen
pbmc
thaw
immedi
wash
rpmi
medium
contain
fb
cell
resuspend
rpmi
media
costimul
h
co
peptid
mfap
cultur
h
pma
ngml
ionomycin
sigmaaldrich
st
loui
mo
cultur
medium
contain
golgistop
contain
monensin
bd
bioscienc
san
jose
ca
block
protein
secret
peptid
amino
acid
length
overlap
five
amino
acid
adjac
peptid
peptid
use
final
concentr
peptid
per
ml
control
cell
cultur
volum
acetonitril
water
peptid
follow
incub
cell
stain
livedead
aquafluoresc
reactiv
dye
dump
gate
blue
min
tabl
follow
surfac
stain
cell
fix
permeabil
cytofixcytoperm
bd
bioscienc
san
jose
ca
min
cell
stain
antibodi
counterstain
antitnfalphadylight
h
room
temperatur
tabl
cell
wash
fix
bd
stabil
fix
analyz
fac
use
bd
facscelesta
bd
bioscienc
san
jose
ca
diva
softwar
flow
cytometr
acquisit
analysi
sampl
perform
least
event
postacquisit
analys
perform
flowjo
treestar
ashland
data
shown
graph
repres
valu
mfap
peptidestimul
cell
background
valu
subtract
bd
compbead
bd
bioscienc
san
jose
ca
use
singlecolor
control
compens
signific
postand
prevaccin
data
determin
fisher
least
signific
differ
lsd
test
twoway
analysi
varianc
anova
vaccin
antigen
express
replicationdefect
recombin
chimpanze
adenovirus
serotyp
also
call
one
vaccin
mous
fap
describ
previous
other
construct
carri
fuse
gd
genet
integr
purifi
vector
confirm
restrict
enzym
digest
viral
dna
follow
gel
electrophoresi
genet
stabil
confirm
propag
vector
passag
follow
purif
viral
dna
restrict
enzym
digest
reveal
band
pattern
digest
conduct
virus
earli
passag
protein
express
test
western
blot
hek
cell
infect
infecti
unit
iu
vector
probe
antibodi
gd
virus
steril
free
endotoxin
detect
limit
assay
euml
vector
viru
particl
vp
infecti
unit
ratio
respect
five
male
healthi
beagl
month
age
enrol
etcr
dog
receiv
standard
vaccin
canin
virus
adenoviru
type
parainfluenza
distemp
parvo
viru
corona
viru
rabi
viru
papilloma
viru
receiv
oral
bordetella
vaccin
check
need
treat
intestin
parasit
purchas
dog
acclimat
week
dog
weight
temperatur
overal
health
check
blood
collect
vaccin
clinic
chemistri
hematolog
anim
vaccin
intramuscularli
differ
site
vp
vector
vp
vector
vp
vector
safeti
vaccin
assess
daili
evalu
dog
gener
health
observ
includ
rectal
temperatur
measur
clinic
health
observ
made
h
vaccin
physic
examin
day
clinic
patholog
analys
hematolog
plasma
chemistri
h
postvaccin
four
five
dog
transient
lost
weight
first
day
vaccin
fig
treat
veterinarian
conclud
initi
weight
loss
caus
stress
due
handl
frequent
bleed
temperatur
stay
within
normal
rang
studi
period
fig
blood
chemistri
includ
test
alt
fig
total
bilirubin
latter
dog
time
point
data
shown
liver
function
glucos
pancrea
function
fig
urea
nitrogen
kidney
function
fig
well
electrolyt
total
protein
shown
blood
chemistri
valu
remain
within
normal
rang
throughout
studi
hematolog
abnorm
observ
data
shown
vaccin
trial
termin
day
vaccin
six
minor
temporari
alimentari
abnorm
form
vomit
mucu
fece
observ
tabl
one
dog
vomit
within
initi
period
vaccin
advers
event
due
inflammatori
reaction
would
expect
peak
health
abnorm
identifi
follow
vaccin
physic
examin
conduct
day
postvaccin
none
anim
requir
veterinari
treatment
follow
vaccin
end
studi
dog
releas
adopt
dog
bled
vaccin
day
vaccin
peripher
blood
mononuclear
cell
pbmc
prepar
test
intracellular
cytokin
stain
ic
stimul
period
presenc
secret
inhibitor
peptid
overlap
end
five
amino
acid
adjac
peptid
span
sequenc
mfap
posit
control
cell
stimul
phorbol
pma
neg
control
cell
cultur
without
peptid
avoid
excess
bleed
volum
immun
respons
analyz
stimul
cell
stain
panel
antibodi
cell
identifi
cell
posit
neg
cell
subdivid
activ
cell
stain
increas
upon
stimul
higher
rest
activ
cell
cell
test
intracellular
interferon
ifn
interleukin
il
tumor
necrosi
factor
tnf
stain
analyz
flow
cytometri
gate
flowjo
shown
suppl
fig
posit
control
sampl
dog
show
increas
frequenc
cytokineproduc
cell
mfap
upon
gate
differ
cytokin
respons
boolean
gate
use
calcul
overal
respons
sum
cytokineproduc
cell
highest
day
reflect
mainli
increas
product
fig
respons
mfap
peak
later
day
domin
cell
produc
fig
restrict
gate
activ
cell
increas
frequenc
cell
respond
mfap
peptid
pool
fig
broaden
cytokin
profil
higher
frequenc
cell
produc
without
cell
also
increas
frequenc
mfapspecif
cell
narrow
gate
exclud
cell
show
shift
kinet
peak
frequenc
peptid
pool
day
time
cell
secret
mainli
alon
combin
fig
f
individu
dog
develop
peak
respons
differ
time
shown
fig
b
rate
respond
defin
dog
sum
tcell
respons
respons
individu
cytokin
test
cell
popul
least
doubl
frequenc
cytokin
cell
baselin
individu
dog
show
differ
respons
two
antigen
differ
cell
popul
well
differ
cytokin
fig
analyz
respons
sum
cytokinesecret
cell
show
two
five
dog
met
criteria
posit
respons
show
increas
one
posit
upon
analysi
cell
respons
rate
increas
three
five
dog
fig
restrict
gate
cell
markedli
reduc
baselin
respons
show
respons
four
five
dog
fig
increas
respons
mainli
seen
respons
rate
higher
mfap
upon
gate
cell
four
five
dog
qualifi
respond
gate
cell
show
respons
anim
respons
mainli
reflect
increas
cell
tcell
respons
mfap
cell
unlik
cell
show
distinct
popul
cell
within
gate
therefor
analyz
cell
cell
cytokin
respons
tcell
respons
antigen
peak
day
vaccin
increas
seen
mainli
cell
produc
respons
contract
sharpli
day
vaccin
fig
b
respons
cell
peak
earlier
day
mainli
reflect
cell
respons
mfap
highest
day
show
increas
cell
fig
overal
kinet
tcell
peak
respons
fairli
uniform
dog
respons
peak
day
cell
came
earlier
peak
day
two
dog
one
dog
show
delay
peak
respons
day
fig
b
dog
show
posit
tcell
respons
one
score
respons
upon
restrict
analysi
cell
dog
respons
one
dog
show
posit
respons
fig
tcell
respons
less
pronounc
mfap
three
five
dog
score
posit
upon
analysi
cell
respons
rate
increas
gate
narrow
cell
fig
cancer
vaccin
develop
combat
malign
companion
anim
approach
activ
immunotherapi
explor
use
human
prohibit
expens
checkpoint
blockad
adopt
tcell
transfer
one
canin
cancer
vaccin
xenogen
dna
vaccin
encod
human
tyrosinas
protein
develop
licens
us
treatment
dog
malign
melanoma
vaccin
base
dna
vector
gener
well
toler
studi
dog
system
reaction
occur
local
hematoma
pain
inject
site
initi
studi
indic
oncept
improv
dog
prognosi
anoth
retrospect
studi
medic
record
dog
review
includ
dog
stage
ii
iii
diseas
treat
oncept
vaccin
appropri
achiev
locoregion
cancer
control
review
found
dog
receiv
vaccin
achiev
greater
progressionfre
surviv
diseasefre
interv
median
surviv
time
dog
receiv
vaccin
similar
result
obtain
studi
conduct
uk
vaccin
shown
induc
bcell
respons
unlik
limit
melanoma
progress
anoth
canin
melanoma
vaccin
term
base
autolog
tumor
lysat
also
induc
antibodi
respons
report
improv
surviv
dog
addit
vaccin
target
type
common
canin
cancer
produc
promis
result
underscor
use
vaccin
viabl
option
treatment
dog
cancer
describ
result
preclin
dog
trial
assess
safeti
immunogen
checkpoint
blockad
cancer
vaccin
effort
focus
melanoma
use
combin
melanoma
vaccin
base
vector
express
maa
fuse
checkpoint
inhibitor
gd
combin
second
vector
express
mfap
induct
cell
caf
similar
vaccin
demonstr
efficaci
melanomabear
mice
vector
chosen
vaccin
deliveri
vehicl
previou
studi
show
except
immunogen
induc
potent
sustain
transgen
productspecif
tcell
respons
point
howev
vaccin
unlik
dna
vaccin
given
neutral
antibodi
induc
vaccin
carrier
reduc
efficaci
upon
repeat
administr
overcom
use
serolog
distinct
ad
vector
booster
immun
dog
commonli
immun
canin
adenoviru
serotyp
acquir
neutral
antibodi
upon
natur
infect
neutral
antibodi
adenovirus
serotyopeand
speciesspecif
antibodi
thu
interfer
immunogen
chimpanzeederiv
ad
vector
fap
highli
conserv
differ
speci
express
fibroblast
within
human
canin
cancer
therefor
select
target
tumor
stroma
increas
respons
fap
vaccin
express
mous
sequenc
show
homolog
correspond
canin
protein
fap
select
express
caf
site
wound
heal
chronic
inflamm
previou
studi
mice
show
fap
fibroblast
essenti
driver
tumor
progress
addit
studi
need
confirm
fap
express
role
fap
target
caf
also
crucial
inhibit
growth
canin
melanoma
elimin
fap
cell
cart
cell
result
signific
toxic
mice
approach
induc
cell
mfapexpress
vaccin
well
toler
mice
shown
dog
mfap
immunogen
dog
treat
dog
develop
tcell
respons
protein
shown
overexpress
canin
melanoma
cell
use
vaccin
antigen
mice
maa
induc
strong
tcell
respons
increas
respons
preserv
cell
function
dog
melanoma
express
fusion
protein
within
gd
hvem
first
identifi
receptor
gd
bimod
switch
express
mani
cell
includ
antigenpres
cell
interact
immunoregulatori
molecul
lymphocyt
bind
hvem
light
lymphotoxin
provid
stimulatori
signal
bind
btla
activ
inhibitori
pathway
coactiv
coinhibitor
bind
differ
domain
hvem
form
trimolar
complex
signal
coinhibitor
domin
n
terminu
gd
bind
site
hvem
close
bind
site
therebi
block
immunoinhibitori
costimulatori
hvem
signal
shown
previous
vaccin
express
antigen
fuse
cterminu
gd
elicit
enhanc
tcell
respons
link
blockad
immunoinhibitori
hvem
pathway
adjuv
vaccin
antigen
gd
especi
effect
augment
tcell
respons
age
mice
mice
advanc
cancer
effect
gd
local
site
immun
rather
system
antibodybas
checkpoint
inhibitor
thu
minim
side
effect
express
within
gd
immunogen
elicit
tcell
respons
healthi
dog
includ
control
vector
express
wildtyp
thu
assess
gd
augment
tcell
respons
surfac
marker
canin
cell
less
well
defin
nonhuman
primat
human
tcell
marker
latter
speci
activ
cell
identifi
increas
express
level
express
distinguish
low
effector
cell
memori
cell
high
use
two
addit
stain
reveal
cell
distinct
popul
low
high
cell
trend
toward
increas
frequenc
fapspecif
cell
high
gate
stain
show
two
distinct
popul
within
high
gate
tcell
popul
frequenc
fapspecif
cell
select
increas
day
time
point
may
suggest
loss
express
cell
might
necessarili
reflect
canin
effector
cell
would
expect
show
maxim
frequenc
earli
immun
summari
preclin
trial
show
canin
melanoma
vaccin
combin
safe
local
system
side
effect
relat
vaccin
vaccin
also
induc
transgen
productspecif
tcell
respons
open
path
toward
test
companion
dog
melanoma
